Carlyle Group Buying WellDyneRX
Terms weren’t announced in the sale of the Lakeland-based pharmacy benefits manager, but the Wall Street Journal said the company could be valued at $1 billion.
Terms weren’t announced in the sale of the Lakeland-based pharmacy benefits manager, but the Wall Street Journal said the company could be valued at $1 billion.